Visualmed vs AHA ACLS Uso & Estadísticas

Introducing Visualmed: The Ultimate Healthcare Companion for Medical Professionals and Visual Learners Stay ahead of the curve with Visualmed, the essential reference tool designed exclusively for physicians, residents, trainees, nurse practitioners, physician assistants, pharmacists, EMTs, and other healthcare professionals. Our app brings you concise, visually engaging summaries of landmark and practice-changing clinical trials in both medicine and surgery as visual abstracts or infographics, allowing you to stay up-to-date with the latest medical literature at your fingertips. Visualmed revolutionizes the way you access critical information, making it the perfect companion for rounds, patient consultations, and professional development. Whether you're a seasoned expert, a budding practitioner, or a visual learner, this app empowers you to deliver evidence-based care with confidence. Key features of Visualmed include: - Comprehensive library: Access a vast collection of visual abstracts and infographics summarizing ground-breaking clinical trials across various medical and surgical fields. - Regular updates: Stay current with the latest publications as our dedicated team continuously adds new trials to the app. - User-friendly interface: Navigate through an intuitive layout that prioritizes efficiency and ease of use, allowing you to find the information you need in seconds. - Favorites and bookmarks: Save your most-referenced trials for quick access anytime, anywhere. - Shareable content: Facilitate discussions and collaborations by sharing visual abstracts and infographics with colleagues through email, social media, or messaging apps. - Reliable references: Trust in the quality of our content, as each abstract is linked to the original published article for further reading. - Visual learning: Enhance your understanding of complex medical data with visually appealing abstracts and infographics that convey key points in no time. With Visualmed, you'll never miss a beat in the rapidly evolving world of healthcare. Join the growing community of medical professionals and visual learners who trust our app to enhance their practice and elevate patient care. Download Visualmed now and experience the future of medical knowledge at your fingertips.
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

The AHA ACLS app is the American Heart Association's (AHA) officially endorsed digital health solution to assist clinicians in running codes and delivering bedside ACLS care with actual patients. The app was developed by Harvard-trained physicians, in collaboration with the AHA, to help fellow physicians, nurses, physician assistants, nurse practitioners, and emergency medical technicians (EMT) deliver the highest level of advanced cardiac life support (ACLS) at the point-of-care. It began as a project to assist clinicians within Massachusetts General Hospital (MGH), a Harvard Medical School teaching hospital—and then expanded to have a global scope after significant positive impact was demonstrated. Importantly, real-time feedback from our clinician users continuously drives improvements in app design, features, and function so that you will have the best experience providing life-saving care at the bedside. The AHA ACLS app is the only one to have all content vetted by both the AHA science team and practicing Harvard-affiliated physicians. It also features the latest 2020 release of AHA recommendations for ACLS. We owe it to our patients to use the best digital health tools to give them the highest chance of surviving acute life-threatening cardiac illnesses. To this end, we have developed a low cost, intuitive, and rigorously vetted mobile app to assist clinicians— including in all stages of training—and enhance ACLS care at the bedside. Features: - Intuitive design to rapidly access 4 ACLS algorithms (i.e. cardiac arrest, tachycardia with pulse, bradycardia with pulse, and post cardiac arrest care) - Includes all ACLS content including drug therapy and dosing, reversible causes, etc. - Easy-to-read timers and ability to log rounds of CPR, epinephrine, and defibrillations - Button within cardiac arrest algorithm that allows for rapid transition to post cardiac arrest care pathway once patient achieves ROSC - All content rigorously vetted by AHA science team and practicing Harvard-affiliated physicians - Regularly updated with the most up-to-date ACLS content We continue to iterate based on real-time clinician feedback, so that you will have the best experience providing life-saving care at the bedside. AHA ACLS offers an auto-renewing annual subscription at $2.99/year with a 3-day free trial. You will have unlimited access to all content while you maintain an active subscription. Payment will be charged to the credit card connected to your Apple ID Account when you confirm the initial subscription purchase. Subscriptions automatically renew unless auto-renew is turned off at least 24-hours before the end of the current subscription period. Your account will be charged for renewal within 24-hours prior to the end of the current period. You may manage your subscription and auto-renewal may be turned off by going to your Account Settings after the purchase. Any unused portion of the free trial period, if offered, will be forfeited when you purchase a subscription. You can read more about our terms and conditions in the app. Icons by Icons8
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

Visualmed frente a AHA ACLS: comparación de la clasificación

Comparar la tendencia de clasificación de Visualmed en los últimos 28 días con AHA ACLS

Rank

No hay datos disponibles

Comparación de las clasificaciones Visualmed frente a AHA ACLS por países

Comparar la tendencia de clasificación de Visualmed en los últimos 28 días con AHA ACLS

Todas las categorías

No hay datos disponibles

Medicina

App
País principal
Clasificación
- -
- -
#182

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
Visualmed VS.
AHA ACLS

23iciembre d, 2024